| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/24/2003 | WO2003059325A1 Magnetic delivery compositions |
| 07/24/2003 | WO2003059323A2 Stable salts of o-acetylsalicylic acid containing basic amino acids ii |
| 07/24/2003 | WO2003059321A1 Use of oligomers and polymers for drug solublization, stabilization, and delivery |
| 07/24/2003 | WO2003059319A1 Drug nanoparticles from template emulsions |
| 07/24/2003 | WO2003059317A2 Medicinal aerosol compositions with a functionalized polyethyleneglycol excipient |
| 07/24/2003 | WO2003059316A1 Medicinal aerosol formulations comprising ion pair complexes |
| 07/24/2003 | WO2003059298A1 Alkyl- and/or alkylene oligoglycoside betaine ester quaternaries |
| 07/24/2003 | WO2003059296A2 Compositions comprising collagen and metalloprotease inhibitors |
| 07/24/2003 | WO2003059288A2 Liposome drug delivery of polycyclic, aromatic, antioxidant or anti-inflammatory compounds |
| 07/24/2003 | WO2003059286A2 Methods and compositions for oxygen transport comprising modified hemoglobin in plasma |
| 07/24/2003 | WO2003059284A2 Composition and method for inhibiting hypersensitivity |
| 07/24/2003 | WO2003059274A2 Vitamin formulation for cardiovascular health |
| 07/24/2003 | WO2003059273A2 Antibody-avidin fusion proteins as cytotoxic drugs |
| 07/24/2003 | WO2003059263A2 Inorganic nanoparticles to modify the viscosity and physical properties of ophthalmic and otic compositions. |
| 07/24/2003 | WO2003059251A2 Antibody targeting compounds |
| 07/24/2003 | WO2003059246A2 Methods of using conjugates of saccharides and acetamidino or guanidino compounds for treating bacterial infections |
| 07/24/2003 | WO2003059221A1 Composition and method for inhibiting hypersensitivity |
| 07/24/2003 | WO2003059194A2 Use of synthetic inorganic nanoparticles as carriers for ophthalmic and otic drugs |
| 07/24/2003 | WO2003059088A1 Stable hygroscopic compositions and methods for stabilizing hygroscopic ingredients |
| 07/24/2003 | WO2003059082A1 Center-filled chewing gum containing calcium |
| 07/24/2003 | WO2003059072A1 Cultured and encapsulated pancreatic stem cells |
| 07/24/2003 | WO2003059069A1 Methods for preserving ophthalmic solutions and preserved ophtalmic solutions |
| 07/24/2003 | WO2003029291A3 Pegylated and diglycosylated erythropoietin |
| 07/24/2003 | WO2003028713A3 3,4-methylenedioxy-substituted chalcones as therapeutic agents |
| 07/24/2003 | WO2002094179A3 Novel topical microbicidal compositions |
| 07/24/2003 | WO2002074807A3 Chimpanzee erythropoietin (chepo) - immunoadhesins |
| 07/24/2003 | WO2002049669A3 Electrically responsive promoter system |
| 07/24/2003 | WO2002049575A3 Method and composition for the treatment of diabetic neuropathy |
| 07/24/2003 | WO2002020059A3 Vibrio cholerae o139 conjugate vaccines |
| 07/24/2003 | WO2002011758A8 Vaccine against the influenza virus and method for producing said virus vaccine |
| 07/24/2003 | US20030139582 Composition containing biologically active polypeptides suitable for the oral administration |
| 07/24/2003 | US20030139580 Tumour necrosis factor binding ligands |
| 07/24/2003 | US20030139577 Tumour necrosis factor binding ligands |
| 07/24/2003 | US20030139575 Cytokine immunoconjugates |
| 07/24/2003 | US20030139495 Aqueous solution of polymer and chitosan; drug delivery |
| 07/24/2003 | US20030139470 3,4-dihydroxybenzyl-substituted carbonic acid derivatives and the use thereof as antioxidants |
| 07/24/2003 | US20030139444 Storage stability; mixture containing glycine hydrochloride |
| 07/24/2003 | US20030139437 Respiratory system disorders; dextromethorphan in anhydrous solvents |
| 07/24/2003 | US20030139436 Stabilized liquid preparation |
| 07/24/2003 | US20030139384 Transdermal supplying testosterone |
| 07/24/2003 | US20030139383 Respiratory system disorders |
| 07/24/2003 | US20030139382 Method of treating middle ear infections |
| 07/24/2003 | US20030139378 Liquid bisphosphonate formulations for bone disorders |
| 07/24/2003 | US20030139361 Organ grafting; antiinflammatory agents, autoimmune disease |
| 07/24/2003 | US20030139353 Using topoisomerase inhibitor; antiarthritic agents; respiratory system disorders; skin disorders |
| 07/24/2003 | US20030139347 Pralmorelin-containing nasal drop preparations |
| 07/24/2003 | US20030139346 Polymer stabilized neuropeptides |
| 07/24/2003 | US20030139340 Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (TFPI) |
| 07/24/2003 | US20030139339 Treatment of severe pneumonia by administration of tissue factor pathway inhibitor ( TFPI) |
| 07/24/2003 | US20030139325 Complex comprising OCIF and polysaccharide |
| 07/24/2003 | US20030138944 Method of transducing a protein into cells |
| 07/24/2003 | US20030138864 Comparing expression levels of genes or proteins in human tissue or cells from normal and tumor origin, selecting enzyme of which mRNA or protein levels in tumor tissue are higher by two-fold as compared to normal cells or tissue |
| 07/24/2003 | US20030138548 Weight management system for obese animals |
| 07/24/2003 | US20030138547 Pet food includes 35-70% by weight protein, 4-10% by weight fat, 5-25% by weight fiber, 10-35% by weight digestible carbohydrate, 0.1-1% by weight functional ingredient to build lean muscle mass |
| 07/24/2003 | US20030138518 Center-filled chewing gum containing a deliverable form of calcium |
| 07/24/2003 | US20030138510 Stabilizing proanthocyanidin with an amino acid having a hydroxyl group or its dipeptide |
| 07/24/2003 | US20030138505 Intradermal-penetration agents for topical local anesthetic administration |
| 07/24/2003 | US20030138503 Topical pharmaceutical formulations and methods of treatment |
| 07/24/2003 | US20030138494 Topical applying a therapeutic prostaglandins to cause vasodilation, active material dispersed in a gel polymer blends containing an anionic polymer and a nonionic polymer |
| 07/24/2003 | US20030138493 Methods for treating ovarian cancer, poly (phosphoester) compositions, and biodegradable articles for same |
| 07/24/2003 | US20030138491 Microencapsulation and sustained release of biologically active acid-stable or free sulfhydryl-containing proteins |
| 07/24/2003 | US20030138490 A controlled-release pharmaceutical drug delivery system comprising active material drug and crosslinkable polymers |
| 07/24/2003 | US20030138489 An aqueous solution comprising of propofol, poloxamers; noncontamination, stability |
| 07/24/2003 | US20030138488 Pharmaceutical formulation for regulating the timed release of biologically active compounds based on a polymer matrix |
| 07/24/2003 | US20030138482 A film-forming composition comprising carrageenan, a bulking agent, plasticizer and water; encapsulating medicinal dosage forms, nutritional supplements, cosmetics, bath oils and gels, and paint balls |
| 07/24/2003 | US20030138481 Liposomes |
| 07/24/2003 | US20030138474 Have both hydrophilic and hydrophobic blocks; form micelles in aqueous solution, making them suitable for encapsulation or solubilization of hydrophobic or water-insoluble materials; controlled drug delivery |
| 07/24/2003 | US20030138462 Prepared by slurrying pamidronic acid in water, combining with aqueous sodium hydroxide in a 2:1 molar ratio, sealing in unit dosage forms |
| 07/24/2003 | US20030138460 For immobilizing an animal for treatment by administration of botulinum toxin serotype and a polysaccharide stabilizer; veterinary medicine |
| 07/24/2003 | US20030138458 HCV E1E2 vaccine compositions |
| 07/24/2003 | US20030138455 Urogential or anorectal transmucosal vaccine delivery system |
| 07/24/2003 | US20030138453 Microparticles comprise a polymer such as a poly(alpha-hydroxy acid), polyhydroxy butyric acid, polycaprolactone, a polyorthoester, a polyanhydride, formed using cationic, anionic, or nomonic detergents; drug delivery |
| 07/24/2003 | US20030138448 An immunogenic conjugate comprising a plurality of deacylated lipopolysaccharide molecules from a gram-negative bacterium covalently linked to gucosamine residue of D.discodideum proteinase 1 |
| 07/24/2003 | US20030138444 Composition and method for treating HIV infection |
| 07/24/2003 | US20030138437 Botulinum toxin and a polysaccharide, such as a hydroxyethyl starch, free of any blood or serum derived proteins, filtrates or fractions useful for diagnostic, therapeutic and/ or research |
| 07/24/2003 | US20030138434 Containing an immunogen, a first adjuvant functioning as a directing molecule and a second adjuvant functioning as a stimulant which are chemically distinct |
| 07/24/2003 | US20030138433 Contacting isolated B-cell in vitro with a target antigen conjugate to produce target antigen manipulated B cells, fusing manipulated cells into the subject |
| 07/24/2003 | US20030138432 Selective cellular targeting: multifunctional delivery vehicles, multifunctional prodrugs, use as antineoplastic drugs |
| 07/24/2003 | US20030138417 Comprising a succinate of histadine buffer having pH from 5.5-6.5, polysorbate, and a tonicity modifier to contribute to the isotonicity, e.g., NaCl or MgCl2; storage stability of 1-2 years; antiagglomerants |
| 07/24/2003 | US20030138413 Activating dendritic cells from the host which are rendered hyporesponsive to activation stimuli by the disease by administering a tumor-derived DC inhibitory factor antagonist in combination with a Toll-like receptor agonist |
| 07/24/2003 | US20030138404 Interferon antagonists useful for the treatment of interferon related diseases |
| 07/24/2003 | US20030138403 Interferon formulations |
| 07/24/2003 | US20030138402 Dry compositions |
| 07/24/2003 | US20030138398 Chemically bonding polyrotaxane molecules through the cyclic molecules or rotators; contact lens, biomaterial, medical material, tires, coatings and adhesives |
| 07/24/2003 | US20030138396 Administering a lipase inhibitor and a pharmaceutically acceptable bile acid sequestrant; anticholesterol agents |
| 07/24/2003 | US20030138381 Medicinal aerosol compositions with an amide and/or ester containing excipient compound |
| 07/24/2003 | US20030138369 As an additive in pharmaceutical, food, agricultural, personal care, home care and like products, which increases the disintegration rate of the formed product, and has high oil absorptive properties |
| 07/24/2003 | US20030137067 Compositions having a combination of immediate release and controlled release characteristics |
| 07/24/2003 | CA2841097A1 Albumin fusion proteins |
| 07/24/2003 | CA2651604A1 Method for preparation of substantially amorphous telmisartan |
| 07/24/2003 | CA2473893A1 Stable salts of o-acetylsalicylic acid with basic amino acids ii |
| 07/24/2003 | CA2472395A1 Pantoprazole cyclodextrin inclusion complexes |
| 07/24/2003 | CA2472170A1 Pharmaceutical compositions comprising polyanionic polymers and amphiphilic block copolymers and methods of use thereof to improve gene expression |
| 07/24/2003 | CA2471907A1 Antibody-avidin fusion proteins as cytotoxic drugs |
| 07/24/2003 | CA2471899A1 Methods of using conjugates of saccharides and acetamidino or guanidino compounds for treating bacterial infections |
| 07/24/2003 | CA2471483A1 Polytartrate composition |
| 07/24/2003 | CA2471192A1 Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments |
| 07/24/2003 | CA2470571A1 Povidone-containing carriers for polypeptide growth factors |
| 07/24/2003 | CA2470533A1 Drug nanoparticles from template emulsions |
| 07/24/2003 | CA2470524A1 Use of oligomers and polymers for drug solublization, stabilization, and delivery |